Company Email Format Management

Codagenix Inc.

Biotechnology Research Farmingdale, New York, United States 22 employees

Employees: 22
Contacts: 3
Emails: 3
Phones: 1

codagenix.com LinkedIn Crunchbase

Codagenix Inc. Overview

Headquarters: Farmingdale, New York, United States
Phone Number: Available in AeroLeads
Website: codagenix.com
Industry: Biotechnology Research
Employees: 22
Founded: 2011
Funding: 5.9M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Live-attenuated vaccine design infectious disease Synthetic biology virology clinical trials vaccines influenza RSV dengue oncolytics

About Codagenix Inc.

Codagenix Inc. is a clinical stage biotechnology company with vaccine products against influenza, respiratory syncytial virus, dengue virus, and others currently under development. Codagenix uses a computer-based algorithm, called SAVE (Synthetic Attenuated Virus Engineering) to design viral genomes that are identical to the wild type strain at the amino acid level, but make less protein in human cells. The highly attenuated viruses make excellent vaccines or oncolytics against solid tumors. Codagenix represents the next wave in vaccine technology, untethered from traditional, time-consuming and unpredictable approaches to attenuating viruses.

Codagenix Inc. Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 1; 25.0% coverage

Codagenix Inc. Org Chart

Sample employees and titles

Name	Title	Location	Contact
Jill Howe	Chief Financial Officer	San Diego, California, United States	Email Phone
Linda Maldonado	VP, Biologics Cmc at Codagenix, Inc.	Edgewater, Maryland, United States	Email
Kimber Poffenberger	Chief Strategy Officer	Washington Dc-baltimore Area, United States	Email
Paul Grint	Experienced Biopharmaceutical Executive		View